Severe reversible left ventricular systolic and diastolic dysfunction due to accidental iatrogenic epinephrine overdose

Reviews in Cardiovascular Medicine

Volumn 5, Issue 2, 2004, Pages 130-133

  Budhwani, Navin ^a   Bonaparte, Kenneth L ^a   Cuyjet, Aloysius B ^a   Saric, Muhamed ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Echocardiography; Epinephrine; Left ventricular dysfunction; Stunning

Indexed keywords

ADRENALIN; BIOCHEMICAL MARKER; CREATINE KINASE MB; DIPHENHYDRAMINE; DOPAMINE; LIDOCAINE; TROPONIN I;

ACCIDENT; ADULT; AKINESIA; ALLERGIC REACTION; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; DIASTOLE; DISEASE SEVERITY; DOPPLER FLOWMETRY; DRUG INDUCED DISEASE; DRUG LABELING; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; ELECTROSURGERY; FEMALE; GYNECOLOGIC SURGERY; HEART DISEASE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE NECROSIS; HUMAN; MEDICAL ERROR; MEDICAL STAFF; PAPANICOLAOU TEST; PERSONNEL MANAGEMENT; STUNNED HEART MUSCLE; TRANSTHORACIC ECHOCARDIOGRAPHY; UTERINE CERVIX;

ADMINISTRATION, INTRAVAGINAL; ADULT; EPINEPHRINE; FEMALE; HUMANS; MEDICATION ERRORS; NEW JERSEY; OVERDOSE; VASOCONSTRICTOR AGENTS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 3042616443     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sardesai SH, Mourant AJ, Sivathandon Y, et al. Phaeochromocytoma and catecholamine induced cardiomyopathy presenting as heart failure. Br Heart J. 1990;63:234-237.
2. Simons M, Downing SE. Coronary vasoconstriction and catecholamine cardiomyopathy. Am Heart J. 1985;109:297-304
3. Salathe M, Weiss P, Ritz R. Rapid reversal of heart failure in a patient with phaeochromocytoma and catecholamine-induced cardiomyopathy who was treated with captopril. Br Heart J. 1992;68:527-528.
4. Lange RA, Hillis LD. Cardiovascular complications of cocaine use. N Engl J Med. 2001; 345:351-358.
5. Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion abnormalities in subarachnoid hemorrhage: an echocardiographic study. J Am Coll Cardiol. 1988;12:600-605.
6. Schurmeyer TH, Engeroff B, Dralle H, von zur Muhlen A. Cardiological effects of catecholamine-secreting tumours. Eur J Clin Invest. 1997;27:189-195.
7. Rona G. Catecholamine cardiotoxicity. J Mol Cell Cardiol.1985;17:291-306.
8. Yamanaka O, Yasumata F, Nakamura T, et al. Myocardial "stunning"-like phenomenon during a crisis of pheochromocytoma. Jpn Circ J. 1994;58:737-742.
9. Bolli R, Marban E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev. 1999;79:609-634.
10. Scott IU, Gutterman DD. Pheochromocytoma with reversible focal cardiac dysfunction. Am Heart J. 1995;130:909-911
11. Brilakis ES, Young WF Jr, Wilson JW, et al. Reversible catecholamme-induced cardiomyopathy in a heart transplant candidate without persistent or paroxysmal hypertension. J Heart Lung Transplant. 1999;18:376-380.
12. Ahmad, I, Sankaran, R, Al-Addad, A. Rapid reversal of heart failure in a patient with pheochromocytoma and catecholamine-induced myocarditis/cardiomyopathy. J Coll Physicians Surg Pak. 2002;12:562-564.
13. Fyfe AI, Daly PA, Dorian P, Tough J. Reversible "cardiomyopathy" after accidental adrenaline overdose. Am J Cardiol. 1991;67:318-319.
14. Sato Y, Tanaka M, Nishikawa T. Reversible catecholamine-induced cardiomyopathy by subcutaneous injections of epinephrine solution in an anesthetized patient. Anesthesiology. 2000;92:615-619.